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Abstract
OBJECTIVE—The objective of this study was to determine the frequency and clinical
significance of intra-amniotic inflammation in patients with preterm increased uterine contractility
with intact membranes but without cervical change.
METHODS—Amniocentesis was performed in 132 patients with regular uterine contractions and
intact membranes without cervical change. Amniotic fluid was cultured for bacteria and
mycoplasmas and assayed for matrix metalloproteinase-8 (MMP-8). Intra-amniotic inflammation
was defined as an elevated amniotic fluid MMP-8 concentration (>23 ng/mL).
RESULTS—1) Intra-amniotic inflammation was present in 12.1% (16/132); 2) Culture-proven
intra-amniotic infection was diagnosed in 3% (4/132) of patients without demonstrable cervical
change on admission or during the period of observation; and 3) Patients with intra-amniotic
inflammation had significantly higher rates of preterm delivery and adverse outcomes, and shorter
amniocentesis-to-delivery intervals than those without intra-amniotic inflammation (P < .05 for
each). Adverse outcomes included chorioamnionitis, funisitis, and neonatal death.
CONCLUSION—Intra-amniotic inflammation was present in 12% of patients with regular
uterine contractions without cervical change, while culture-proven intra-amniotic infection was
present in 3%. The presence of intra-amniotic inflammation was a significant risk factor for
adverse neonatal outcomes. These observations question whether cervical changes should be
required for the diagnosis of preterm labor, because patients without modifications in cervical
status on admission or during a period of observation are at risk for adverse pregnancy outcomes.
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Introduction
The diagnosis of labor (both term and preterm) is a major challenge in obstetrics [1-6]. The
standard view is that a certain diagnosis of labor can only be made retrospectively once
increased uterine contractility leads to progressive cervical dilatation and impending or
actual delivery [2].
The differential diagnosis between “true” spontaneous labor at term and “false labor”
continues to be a dilemma. Virtually every labor and delivery unit has had the experience of
having discharged a patient with the diagnosis of false labor and then learning that the
patient delivered on her way back to the hospital. In most instances, this does not represent a
problem because term neonates are mature and experience few complications.
On the other hand, a “false negative” diagnosis of preterm labor can have more serious
implications [7-10]. Patients often present to the hospital with increased uterine contractility,
and obstetricians are expected to identify those who have Braxton-Hicks contractions from
those who are in “true” preterm labor. However, there is no “gold standard” to diagnose
“true” preterm labor. Some physicians have introduced the term “threatened preterm labor”
to describe the clinical condition in which a patient has increased uterine contractility with
or without cervical changes.
The standard criteria for the diagnosis of preterm labor recommended by professional
organizations and investigators have changed over time. Decades ago, preterm labor was
suspected purely on the basis of increased uterine contractility; however, when the concept
of tocolysis was introduced into obstetrics, the use of pharmacologic agents (e.g. intravenous
alcohol or non-specific adrenergic agents) administered to achieve uterine relaxation was
associated with serious adverse events which could be lethal to the mother [11-13]. Thus,
the need emerged to identify patients who were at greater risk for preterm delivery in whom
tocolysis “should” be used. This is how a change in cervical status (e.g. progressive cervical
change or cervical changes at the time of diagnosis) became part of the standard criteria to
diagnose preterm labor [14,15]. Patients with such diagnosis would be eligible for the
administration of tocolysis and steroids, while those without cervical change are monitored
and often discharged. Yet, these patients are at increased risk for preterm delivery [16-23].
To address the question of whether patients with an increase in uterine contractility but
without cervical change could have serious pathologic processes, we investigated the
frequency of intra-amniotic infection/inflammation and its clinical significance. The basis
for this is that intra-amniotic infection/inflammation is a risk factor for adverse pregnancy
outcome and neonatal morbidity [24-75].
Materials and Methods
Study population
The study population consisted of consecutive patients who were admitted to Seoul National
University Hospital, Seoul, Republic of Korea, with regular uterine contractions and intact
membranes without cervical change before 35 weeks of gestation. The patients met the
following criteria: (1) singleton gestation; (2) regular uterine contractions - eight or more in
60 minutes; (3) initial cervical dilatation ≤ 1 cm and effacement ≤ 75% by digital cervical
examination and no cervical change for at least 3 hours; and (4) transabdominal
amniocentesis for microbiologic studies or assessment of fetal lung maturity. Patients with
placenta previa or those who had previously undergone a cervical cerclage were excluded.
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The Institutional Review Board of Seoul National University Hospital, Seoul, Republic of
Korea, has approved the collection and utilization of the biological materials and clinical
data for research purposes.
Amniotic fluid
Amniotic fluid was obtained by transabdominal amniocentesis with ultrasound guide and
aseptic technique with written informed consent. Amniotic fluid was cultured for aerobic
and anaerobic bacteria, as well as for genital mycoplasmas (ureaplasmas [Ureaplasma
urealyticum & Ureaplasma parvum] and Mycoplasma hominis), and used for assessment of
fetal lung maturity. The remaining amniotic fluid was centrifuged, and the supernatant was
stored at −70°C until assayed.
Intra-amniotic inflammation was defined as an elevated amniotic fluid matrix
metalloproteinase-8 (MMP-8) concentration (>23 ng/mL), as previously reported [76].
Previous studies indicated that amniotic fluid MMP-8 is a sensitive and specific index of
intra-amniotic inflammation and correlates with an amniotic fluid white blood cell (WBC)
count [77,78]. MMP-8 concentration in the stored amniotic fluid was measured with a
commercially available, enzyme-linked immunosorbent assay (Amersham Pharmacia
Biotech, Inc., Little Chalfont, Buckinghamshire, UK) with a sensitivity of 0.3 ng/mL. Both
inter- and intra- assay coefficients of variation were < 10%.
Acute histologic chorioamnionitis, funisitis and neonatal morbidity
Clinical chorioamnionitis was diagnosed according to definitions previously described in
detail [79]. Acute histologic chorioamnionitis was diagnosed when inflammatory change
was detected in any part of the placental tissue samples (amnion, chorion-decidua and
chorionic plate); funisitis was diagnosed in the presence of neutrophil infiltration into the
umbilical vessel walls or into Wharton’s jelly, according to the criteria previously reported
[80]. Significant neonatal morbidity was defined when any of the following conditions was
diagnosed: proven congenital neonatal sepsis, respiratory distress syndrome, congenital
pneumonia, bronchopulmonary dysplasia, intraventricular hemorrhage (grade ≥II), and
necrotizing enterocolitis. The diagnostic criteria of each condition were described in detail in
previous reports from our group [81].
Statistical analysis
Comparison of the continuous variables was performed by using the Mann-Whitney U test.
Proportions were compared with the Pearson Chi-Square or Fisher’s exact tests. Logistic
regression analysis was used to examine the relationship between the presence of intra-
amniotic inflammation and adverse perinatal outcomes of interest to adjust for potential
confounding factors. Survival analysis was used to compare the amniocentesis-to-delivery
interval according to the presence or absence of intra-amniotic inflammation. Patients
delivered for maternal or fetal indications were treated as censored observations, with a
censoring time equal to the amniocentesis-to-delivery interval. The Cox proportional
hazards model was used to control covariates and to investigate the hazards ratio. A
probability value of < .05 was considered to be of statistical significance.
Results
The frequency of intra-amniotic infection and inflammation
Intra-amniotic inflammation was present in 12.1% (16/132) of the patients with regular
uterine contractions without cervical change, and microorganisms were detected in 3.1% of
these cases (4/130). Microorganisms isolated from amniotic fluid were Ureaplasma
urealyticum (n=2), Mycoplasma hominis and Streptococcus anginosus (n=1; one patient had
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2 organisms), and Acinetobacter Bauman (n=1). All patients with a positive amniotic fluid
culture had intra-amniotic inflammation. On the other hand, 13 patients with intra-amniotic
inflammation had negative amniotic fluid cultures.
Characteristics of study population
Table I shows the clinical characteristics of the study population according to the presence
or absence of intra-amniotic inflammation. Patients with intra-amniotic inflammation had a
significantly lower median gestational age at amniocentesis than those without inflammation
(P < .05). There were no significant differences in maternal age, parity, interval from
admission to amniocentesis, frequency of uterine contractility and the rate of administration
of tocolysis between patients with and without intra-amniotic inflammation (P > .1, Table I).
Amniocentesis-to-delivery interval
Patients with intra-amniotic inflammation had significantly shorter amniocentesis-to-
delivery intervals than those without intra-amniotic inflammation as demonstrated by
survival analysis (P = .001; Figure 1), and intra-amniotic inflammation was significantly
associated with a short interval to delivery after the adjustment for gestational age (hazards
ratio, 6.9; 95% CI, 3.7-12.5; P < .05, Cox proportional hazards model analysis).
Pregnancy outcome
Table II demonstrates pregnancy and neonatal outcomes of the study population according
to the presence or absence of intra-amniotic inflammation. Patients with intra-amniotic
inflammation had significantly lower median gestational ages at birth and birthweights, and
higher rates of preterm delivery, histologic chorioamnionitis, funisitis, neonatal death, and
admissions to the neonatal intensive care unit than those without intra-amniotic
inflammation (P < .05 for each, Table II).
Subgroup analysis according to the duration of observation of cervical change
The current study included patients with regular uterine contractions and no cervical change
for at least 3 hours. We also included patients with no cervical change for at least 6 hours. In
such patients, the rate of intra-amniotic inflammation was 13.6% (11/81). Table III
compares the outcome between patients with and without intra-amniotic inflammation in
patients with regular uterine contractions and no cervical change for 6 hours or more.
Patients with intra-amniotic inflammation had significantly higher rates of adverse outcomes
than those without inflammation (P < .05 for each). Patients with intra-amniotic infection
had significantly lower gestational ages at birth and birthweights. They also had shorter
amniocentesis-to-delivery intervals and higher rates of preterm delivery, histologic
chorioamnionitis, funisitis, neonatal death and admissions to the neonatal intensive care unit.
We also analyzed our data to focus on patients who did not have cervical change for at least
12 hours. Intra-amniotic inflammation was found in 12.5% (6/48). Similarly, patients with
intra-amniotic inflammation had significantly lower median gestational ages at birth, lower
median birthweights, shorter median intervals to delivery, and higher rates of preterm
delivery, histologic chorioamnionitis, funisitis, and neonatal death than those without
inflammation in patients with regular uterine contractions and no cervical change for at least
12 hours (P < .05 for each).
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Comment
Principal findings of the study
1) Patients with increased preterm uterine contractility and intact membranes but without
cervical change have a prevalence of intra-amniotic inflammation of 12% and culture-
proven intra-amniotic infection of 3%. The organisms found in the amniotic cavity are
similar to those involved in intra-amniotic infection in preterm labor with intact membranes
[82-87] or preterm prelabor rupture of membranes [88-94]; 2) patients with intra-amniotic
inflammation were at risk for preterm delivery and adverse neonatal outcome as well as
histologic chorioamnionitis and funisitis; 3) these data indicate that a fraction of patients
who do not meet the clinical definition of preterm labor as currently recommended by
textbooks and professional organizations are still at risk for preterm delivery, intra-amniotic
infection/inflammation, and adverse pregnancy outcome; and 4) preterm labor and delivery
can occur in patients without cervical change at presentation or within a 12-hour period of
observation.
Intra-amniotic infection/inflammation in patients with preterm labor and intact membranes
and without cervical change
This is the first and only study which focused exclusively on this population and, therefore,
our findings cannot be compared with other reports. However, the presence of microbial
invasion of the amniotic cavity with bacteria has been demonstrated in patients at term not in
labor [95,96], undergoing mid-trimester amniocentesis [97-99], those with an asymptomatic
short cervix [100-104] and those with idiopathic vaginal bleeding [105]. Patients in the latter
two categories have an excess of intra-amniotic infection/inflammation over those who are
at term not in labor or who undergo mid-trimester amniocentesis for genetic indications.
Such observations suggest that subclinical intra-amniotic infection/inflammation may lead to
either a short cervix or vaginal bleeding.
Table IV displays the prevalence of microbial invasion observed in different obstetrical
syndromes [86,101,106-192]. It is noteworthy that, among patients with preterm labor and
intact membranes, the mean frequency of microbial invasion at the time of admission is
approximately 12%. This is four-fold higher than that observed in patients with preterm
labor and intact membranes in the current study, and our observations confirm previous
findings that the more advanced the cervical dilatation or the shorter the cervix in ultrasound
examinations, the higher the frequency of intra-amniotic infection/inflammation
[101,193-197].
We have previously demonstrated a similar prognosis for patients with intra-amniotic
inflammation and a negative amniotic fluid culture and for those with culture-proven intra-
amniotic infection [198-200]. Therefore, the finding reported herein that 12% of patients
with increased preterm uterine contractility have intra-amniotic inflammation and adverse
outcome is of importance because this is the most common presentation of patients
suspected to have preterm labor.
The cause of intra-amniotic inflammation in patients with negative amniotic fluid cultures
can be bacterial infection that escaped detection with cultivation techniques [201,202] or
viral infection [203-205]. We have previously demonstrated that molecular microbiologic
techniques are able to identify microbial footprints in patients with intra-amniotic
inflammation but negative amniotic fluid cultures [86,206-209]. It is possible that, if such
techniques were used, the rate of intra-amniotic infection would be higher. The same applies
for techniques to isolate the presence of viruses.
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The common pathway of parturition
We have proposed that the common pathway of parturition [210,211] involves: 1) increased
uterine contractility; 2) cervical ripening; and 3) membrane/decidual activation. These
components can be activated in a synchronous manner and then the patient with overt
activation of the three components will present with increased uterine contractility, cervical
dilatation, and membrane rupture. Subclinical degrees of activation can occur which can
only be detected with surface electromyography [212-214], cervical ultrasound
[101,215-217], coloscope, or the presence of extracellular matrix proteins, such as
fibronectin in cervico-vaginal fluid, for membrane decidual activation [218-223].
Asynchronous activation of the common pathway can also occur. Hence, the patient can
present with isolated increased uterine contractility, isolated cervical insufficiency,
[224,225] or preterm prelabor rupture of membranes [226,227]. Patients with less overt
signs of asynchronous activation of the common pathway are also observed. Typically, such
patients were the subjects of the present study. However, the greater the number of
components of the common pathway that are activated, the more likely the patient will have
preterm labor that will lead to preterm delivery.
Requirement of cervical change for the diagnosis of preterm labor
The requirement for some degree of change in cervical status for the diagnosis of preterm
labor was introduced in clinical practice to minimize the number of patients who would be
treated with tocolytic agents [228,229]. The primary rationale behind the requirement of
changes in cervical status for the diagnosis of preterm labor was the avoidance of
overtreatment and prevention of adverse events. It was reasoned that if the patient with
isolated preterm uterine contractions would continue to have contractions and the cervix
changed, this would be diagnostic of preterm labor and that such patient would still be in
time for treatment to arrest uterine contractility with tocolysis and for the prevention of
preterm delivery.
Many patients admitted to a labor and delivery unit with the suspicion of preterm labor are
given intravenous hydration. Pircon et al. [230] reported the outcome of 48 patients with
preterm uterine contractions but without cervical change randomized to bed rest (n=28) or
bed rest and hydration (n=20). Twenty-two patients stopped contracting; however, 18%
(4/22) subsequently delivered preterm neonates. Therefore, whatever the apparent short-term
clinical response to hydration might be, patients remain at risk for preterm delivery. This has
also been the case when patients have been randomized to receive a single injection of
subcutaneous terbutaline. Even though contractions are likely to abate, pregnancy outcome
is no different in patients who receive terbutaline than in the control group [231,232].
Collectively, these studies highlight the clinical difficulties of the diagnosis of preterm labor
and that attempts to implement interventions in the hope that they would assist in the
differential diagnosis between true and false preterm labor have not been successful.
Clinical implications of this study
Our observations suggest that patients presenting with an episode of increased preterm
uterine contractility without cervical changes cannot be considered to have false preterm
labor and to be risk-free. Although many clinicians discharge such patients from the labor
and delivery unit, not only do they remain at risk for preterm delivery, but a fraction has
intra-amniotic infection/inflammation and the increased frequency of uterine contractions
may be the only sign of that pathologic process. For these reasons, we propose that the
diagnosis of intra-amniotic infection/inflammation be undertaken, and that management be
changed if that is the case (administration of antibiotics and steroids, and suspension of
tocolysis if initiated) [101,233-235]. Patients can be counseled that those with intra-amniotic
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inflammation will deliver a preterm neonate in 87.5% of cases (see Table II). The absence of
intra-amniotic inflammation reduces the risk of preterm delivery (32.8%; see Table II), and
the pathologic mechanisms responsible for this have not been elucidated but may be related
to chronic chorioamnionitis, which is evidence of maternal anti-fetal rejection [236,237].
Cervical change during the period of observation
Textbooks and investigators recommend that the diagnosis of preterm labor be made if
cervical changes are present at admission, and if such changes are documented during a
period of observation. However, the precise duration of the period of observation and the
miminum change required to make a diagnosis are rarely specified – even when they are, the
scientific basis for this is unclear. It is noteworthy that, in the current study, the frequency of
intra-amniotic infection/inflammation was no different if the patients presented without
cervical change on admission, or if the cervix did not change after 12 hours.
Why would some patients with increased preterm uterine contractility but without cervical
change have intra-amniotic infection/inflammation?
One possibility is that patients have an intra-amniotic infection of hematogenous origin.
Indeed, we and others have found bacteria in amniotic fluid which are normally found in the
oral cavity using molecular techniques [238,239]. This suggests that some patients may have
a bacteremia, and the transplacental passage of the bacteria causes intra-amniotic infection.
Another possibility is that the uterine cavity (decidua) is not sterile during pregnancy, and
bacteria are present in biofilms which do not elicit a robust proinflammatory host response.
However, fracture of the biofilm may result in the release of planktonic bacteria, which
would be capable of multiplication, passage across the membranes, and the induction of
inflammation. We have previously reported that patients who have bacteria in the
chorioamniotic space have a higher mean amniotic fluid IL-6 concentration than those
without bacteria in the chorioamniotic space [240]. IL-6 is a reliable marker of intra-
amniotic inflammation.
A possibility that should not be overlooked is that if the mucus plug is lost or defective
[241-244], microorganisms from the lower genital tract may ascend into the uterus during
uterine contractions. Indeed, a recent study indicated that vaginal fluid can ascend into the
uterine cavity by a suction-like effect caused by uterine contractions (demonstrated
byhystero-salpingo scintigraphy with contrast media) [245]. Therefore, it is possible that
uterine contractions in the appropriate host (one in which the innate immune system is
compromised because of a defective mucus plug or the loss of the mucus plug in patients
with a short cervix) may predispose to ascending intra-amniotic infection/inflammation.
It is noteworthy that 19% of patients with spontaneous labor at term with intact membranes
have a positive amniotic fluid culture [246]. These observations have been confirmed by
studying the microbial state of the amniotic cavity in patients in spontaneous labor at term
undergoing cesarean section [247].
CONCLUSION
This study shows that subclinical intra-amniotic infection/inflammation is present in a
fraction of patients with an episode of preterm labor with intact membranes and without
cervical change. Thus, preterm uterine contractions may be the only clinical manifestation of
intra-amniotic inflammation. However, an important implication of our observation is that
preterm labor leading to preterm delivery can present itself as increased preterm uterine
contractility without cervical change. This observation calls for a re-examination of the
diagnostic criteria for preterm labor.
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Figure 1. Survival analysis of amniocentesis-to-delivery interval
Patients with intra-amniotic inflammation had a significantly shorter amniocentesis-to-
delivery interval than those without inflammation (median, 4.0 days [range, 0.5-109.3 days]
vs. median, 45.9 days [range, 0.0-144.9 days]; log rank, P= .001).
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Table I
Clinical characteristics according to the presence or absence of intra-amniotic inflammation
Intra-amniotic inflammation
P valueNegativea
(n=116)
Positiveb
(n=16)
Maternal age (y)c 30.0 (23-42) 29.5 (25-43) NS
Nulliparity (n) 68 (58.6%) 11 (68.8%) NS
Gestational age at amniocentesis (wk) c 31.6 (19.0-34.9) 28.5 (20.9-34.6) < .05
Interval to amniocentesis from admission
(hr) c 8.0 (3.0-336.0) 8.0 (3.0-272.0) NS
No. of uterine contraction (/hr) d 17.7 ± 8.7 15.4 ± 5.1 NS
Tocolysis at amniocentesis (n) 74 (63.8%) 12 (75.0%) NS
AF, amniotic fluid; MMP-8, matrix metalloproteinase-8; NS, not significant.
aNegative, AF MMP-8 < 23 ng/mL
b
Positive, AF MMP-8 > 23 ng/mL
cValues are given as median (range)
d
Data given as mean ± SD
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Table II
Pregnancy and neonatal outcome according to the presence or absence of intra-amniotic inflammation
Intra-amniotic inflammation P value
Negativea
(n=116)
Positiveb
(n=16) Unadjusted Adjusted c
Gestational age at delivery (wk)d 38.4 (21.4-42.6) 32.7 (21.4-38.3) <.001 –
Amniocentesis-to-delivery interval (n)
            ≤48 hr 7 (6.0%) 5 (31.3%) < .01 < .01
            ≤7 d 15 (12.9%) 12 (75.0%) < .001 < .001
Preterm delivery (n) 38 (32.8%) 14 (87.5%) <.001 < .001
Clinical chorioamnionitis (n) 0 (0.0%) 3 (18.8%) < .01 –
Histologic chorioamnionitis (n/N)e,f 15/66 (22.7%) 7/10 (70.0%) < .01 < .01
Funisitis (n/N)e,f 2/66 (3.0%) 5/10 (50.0%) < .001 < .001
Birthweight (g)d 2930 (390-4200) 1865 (550-2810) < .001 –
1-minute Apgar score <4 (n/N) f 7/92 (7.6%) 4/14 (28.6%) < .05 .054
5-minute Apgar score <7 (n/N) f 5/92 (5.4%) 4/14 (28.6%) < .05 < .05
Neonatal deaths (n/N) g 2/112 (1.8%) 4/16 (25.0%) < .01 < .01
     Shortly after birth,<1 day 1 4
    Perinatal period,<1 month 1 0
Admission to NICU (n/N)f,h 18/92 (19.6%) 7/11 (63.6%) < .01 < .01
Significant neonatal morbidity (n/N)f,h 9/92 (9.8%) 3/11 (27.3%) NS NS
Neonatal mortality and significant
morbidity (n/N) 10/93 (10.8%) 7/15 (46.7%) < .01 < .01
AF, amniotic fluid; MMP-8, matrix metalloproteinase-8; NS, not significant; NICU, neonatal intensive care unit.
aNegative, AF MMP-8 < 23 ng/mL.
b
Positive, AF MMP-8 > 23 ng/mL.
cAdjusted for gestational age at amniocentesis (logistic regression analysis).
dValues are given as median (range).
eCases without placental examination were excluded.
fCases delivered at other hospitals were excluded, most of them were delivered at term without complication.
gCases with major anomaly were excluded.
hCases with major anomaly or died in the delivery room were excluded. Significant neonatal morbidity was defined as the presence of any
following conditions: proven neonatal sepsis, respiratory distress syndrome, pneumonia, bronchopulmonary dysplasia, intraventricular hemorrhage
(grade ≥ II), and necrotizing enterocolitis. Five newborns who died within 1 day with or without resuscitation due to extreme prematurity were
excluded because they could not be evaluated for morbidity.
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Table III
Outcomes in patients with regular uterine contractions and no cervical change for at least 6 hours
Intra-amniotic inflammation P value
Negativea
(n=70)
Positiveb
(n=11) Unadjusted Adjusted c
Gestational age at delivery (wk)d 38.4 (21.4-41.6) 32.1 (21.4-38.3) < .001 –
Amniocentesis-to-delivery interval (n)
            ≤48 hr 4 (5.7%) 4 (36.4%) < .05 < .05
            ≤7 d 9 (12.9%) 8 (72.7%) < .001 < .001
Preterm delivery (n) 20 (28.6%) 10 (90.9%) < .001 < .05
Histologic chorioamnionitis (n/N)e,f 7/38 (18.4%) 4/5 (80.0%) < .05 < .05
Funisitis (n/N)e,f 0 2/5 (40.0%) < .05 –
Birthweight (g)d 2970 (390-4200) 1680 (550-2810) < .001 –
1-minute Apgar score <4 (n/N) f 5/55 (9.1%) 4/9 (44.4%) < .05 < .05
5-minute Apgar score <7 (n/N) f 2/55 (3.6%) 4/9 (44.4%) < .01 < .01
Neonatal deaths (n/N) g 1/68 (1.5%) 4/11 (36.4%) < .01 < .05
Admission to NICU (n/N)f,h 9/55 (16.4%) 4/6 (66.7%) < .05 < .05
Significant neonatal morbidity (n/N)f,h 6/55 (10.9%) 2/6 (33.3%) NS NS
Neonatal mortality and significant
morbidity (n/N) 7/56 (12.5%) 6/10 (60.0%) < .01 < .05
AF, amniotic fluid; MMP-8, matrix metalloproteinase-8; NS, not significant; NICU, neonatal intensive care unit.
aNegative, AF MMP-8 < 23 ng/mL.
b
Positive, AF MMP-8 > 23 ng/mL.
cAdjusted for gestational age at amniocentesis (logistic regression analysis).
dValues are given as median (range).
eCases without placental examination were excluded.
fCases delivered at other hospitals were excluded, most of them were delivered at term without complication.
gCases with major anomaly were excluded.
hCases with major anomaly or died in the delivery room were excluded. Significant neonatal morbidity was defined as the presence of any
following conditions: proven neonatal sepsis, respiratory distress syndrome, pneumonia, bronchopulmonary dysplasia, intraventricular hemorrhage
(grade ≥ II), and necrotizing enterocolitis. Five newborns who died within 1 day with or without resuscitation due to extreme prematurity were
excluded because they could not be evaluate about morbidity.
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Table IV
Prevalence of microbial invasion reported for the different obstetrical syndromes
Obstetrical syndromes Microbial invasion in
amniotic fluid
Term not in labor [86,87] 1%
Term in labor [86,87,125] 4%-19%
Premature rupture of membranes at term [119] 34%
Premature rupture of membranes at preterm
[30,42,58,61,71,75,82,84,96,100,101,103,105,106,117,121,122,126,128,130
,131,134,135,143,145,146,150,151,158]
15%-58%
Preterm labor with intact membranes [22-25,28,32,40,75,78-80,97-
99,102,104,107-118,121,123,124,127,129,132-134,136-
142,144,147,149,159,160]
0%-48%
Cervical insufficiency [72,120,152] 8%-52%
Short cervix [91,94,148] 4%-9%
Small for gestational age [156] 0%
Preeclampsia [155] 2%
Vaginal bleeding [95,153,157] 5%-14%
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